Literature DB >> 10375368

Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease.

L Reynolds1, S Struik, S Nadel.   

Abstract

Two infants with severe varicella are reported. They received varicella zoster immunoglobulin (VZIG) without concurrent information to parents or carers regarding further care. In both these cases there was a three day delay between the onset of symptoms and initiation of aciclovir. This delay was due to lack of awareness of the high risk of varicella in these infants. Infants born to mothers with onset of chickenpox 4 days before to 2 days after delivery are at risk of fatal varicella, despite the use of VZIG prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375368      PMCID: PMC1720945          DOI: 10.1136/fn.81.1.f69

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  3 in total

1.  Effect of zoster immunoglobulin for varicella prophylaxis in the newborn.

Authors:  K Hanngren; M Grandien; G Granström
Journal:  Scand J Infect Dis       Date:  1985

2.  Congenital varicella in term infants: risk reconsidered.

Authors:  J D Meyers
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

3.  Fatal neonatal varicella infection.

Authors:  P Holland; D Isaacs; E R Moxon
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

  3 in total
  1 in total

1.  Varicella infection in a neonate with subsequent staphylococcal scalded skin syndrome and fatal shock.

Authors:  Shakal Narayan Singh; Mohammad Tahazzul; Anita Singh; Surabhi Chandra
Journal:  BMJ Case Rep       Date:  2012-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.